<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01560390</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0108</org_study_id>
    <nct_id>NCT01560390</nct_id>
  </id_info>
  <brief_title>Use of Ketamine Associate With an Opioid for Sedation in ICU</brief_title>
  <acronym>KetaRea</acronym>
  <official_title>Use of Ketamine Associate With an Opioid for Sedation in ICU : a Randomized Controlled Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the impact of ketamine associated to an opioid for
      sedation of mechanically ventilated critically ill patients versus placebo. Sedation will be
      drive by nurses according to an algorithm. The investigators will evaluate the quantity of
      opioates used in each arm and the safety of ketamine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All consecutive mechanically ventilated patients admitted in the intensive care unit
      (ICU)will be randomized to receive an infusion of 0.15 mg/kg/h of kétamine or placebo. Nurses
      and physicians will be blinded of the allocation arm. The infusion of ketamine will be
      stopped as soon as remifentanil will be discontinued by the physician.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of opiate used between study enrollment and mechanical ventilation withdrawal.</measure>
    <time_frame>after 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confusion Duration assessed by CAM-ICU</measure>
    <time_frame>after 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilation duration</measure>
    <time_frame>after 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>after 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality at D28</measure>
    <time_frame>at day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hyperalgesia during sedation</measure>
    <time_frame>after 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">164</enrollment>
  <condition>Sedation for Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Rémifentanil + Kétamine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>to evaluate the impact of ketamine associated to an opioid for sedation of mechanically ventilated critically ill patients versus placebo. Sedation will be drive by nurses according to an algorithm. The investigators will evaluate the quantity of opioates used in each arm and the safety of ketamine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rémifentanil + Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>to evaluate the impact of ketamine associated to an opioid for sedation of mechanically ventilated critically ill patients versus placebo. Sedation will be drive by nurses according to an algorithm. The investigators will evaluate the quantity of opioates used in each arm and the safety of ketamine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rémifentamil + KETAMINE</intervention_name>
    <description>All consecutive mechanically ventilated patients admitted in the ICU will be randomized to receive an infusion of 0.15 mg/kg/h of kétamine or placebo. Nurses and physicians will be blinded of the allocation arm. The infusion of ketamine will be stopped as soon as remifentanil will be discontinued by the physician.</description>
    <arm_group_label>Rémifentanil + Kétamine</arm_group_label>
    <arm_group_label>Rémifentanil + Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine</intervention_name>
    <description>to evaluate the impact of ketamine associated to an opioid for sedation of mechanically ventilated critically ill patients versus placebo. Sedation will be drive by nurses according to an algorithm. The investigators will evaluate the quantity of opioates used in each arm and the safety of ketamine.</description>
    <arm_group_label>Rémifentanil + Kétamine</arm_group_label>
    <arm_group_label>Rémifentanil + Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients under mechanical ventilation

        Exclusion Criteria:

          -  pregnant

          -  psychotic

          -  chronic use of opiates

          -  age &lt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel CONSTANTIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2011</study_first_submitted>
  <study_first_submitted_qc>March 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2012</study_first_posted>
  <last_update_submitted>January 11, 2013</last_update_submitted>
  <last_update_submitted_qc>January 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sedation</keyword>
  <keyword>ICU</keyword>
  <keyword>Ketamine</keyword>
  <keyword>Confusion</keyword>
  <keyword>Hyperalgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

